President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases. 

The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.

"We're going to be able to make that drug available almost immediately," Trump said. 

The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.

He also tempered the president's optimism about the still-untested solution. 

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.  

"The therapies are something we could move on much faster potentially," Trump said. 

He claimed the administration "slashed red tape" to develop new vaccines and therapies.

The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks

"If we find that we need something, then we will do that," he said.  

Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak. 

The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.

"We continue our relentless effort to defeat the Chinese virus," Trump said.

Share:
More In Politics
Volatile 'Mixed Bag' Market Conditions Appear Hard to Read
The ongoing war in Ukraine and the Fed's hawkish stance toward reining in inflation might be causing a frenzy among investors. Craig Erlam, a senior market analyst at foreign exchange OANDA, joined Cheddar News to talk about the current "mixed bag" markets. "It's hard to read too much into it. These are just the market conditions we have right now," he said. "Ultimately we're a little directionless at times overall, but these intraday moves are causing a lot of volatility this week."
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
First-Time Homebuyers Face Rising Mortgage Rates
Buying a new home is tough right now; but for first-time buyers, it's an especially challenging time, with obstacles like rising mortgage rates and record-breaking home prices. The housing market is not expected to get much friendlier, as mortgage rates are expected to continue to climb as the Federal Reserve proceeds with its plans for rate hikes in an effort to stifle inflation. Jonathan Miller, President and CEO of real estate appraiser Miller Samuel, joins Cheddar News' Closing Bell to discuss.
Title 42: What It Is and Why It's Such a Big Deal
Tyler Moran, former senior adviser to President Biden on migration, joins Cheddar Politics to discuss the recent controversy around the administration's decision to end the use of Title 42, a public health order allowing the U.S. to expel migrants without going through the asylum process.
Biden Targets 'Ghost Guns' with New Executive Action
Christian Heyne, vice president of policy at the gun safety group Brady, joins Cheddar Politics to discuss President Biden's executive action on so-called "ghost guns," and to reflect on the Brooklyn subway shooting.
Trump's Dr. Oz Endorsement Turns Heads in MAGA World
Zachary Petrizzo, media reporter at The Daily Beast, joins Cheddar Politics to discuss former President Trump's endorsement of Dr. Oz in the U.S. Senate race in Pennsylvania, and why some parts of the MAGA base are unhappy about it.
Libertarian Larry Sharpe Takes Another Shot for Governor
Larry Sharpe, libertarian candidate for New York governor, joins Cheddar Politics to talk about the issues motivating his campaign. The discusses his endorsement from the progressive Forward party founded by former presidential candidate Andrew Yang, and changes that can be made to voting systems.
Load More